Tags

BioVersys

BioVersys initiates Phase 2b trial for anti infective drug BV100

BioVersys initiates Phase 2b trial for anti infective drug BV100

October 30, 2026 | 14:50
Biotechnology company BioVersys enrolled the first patient in its Phase 2b trial evaluating anti-infective drug candidate BV100 for treating drug-resistant bacterial pneumonia.

Latest News

Ridger deploys private artificial intelligence software for Shum Wong Co

Ridger deploys private artificial intelligence software for Shum Wong Co

Hitachi Construction Machinery launches brand campaign ahead of LANDCROS rename

Hitachi Construction Machinery launches brand campaign ahead of LANDCROS rename

Prudential partners with MediConCen for instant doctor booking software

Prudential partners with MediConCen for instant doctor booking software

Vinhomes Green Paradise enters global vote for future city campaign

Vinhomes Green Paradise enters global vote for future city campaign

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society CSR Swing for the Kids
World News
virs-publications-vir
timeout-vn
ptbv2020